Table 3

Prognosis and development of recent wheeze, airway hyperresponsiveness (AHR), and atopy in the study sample (n=498)

NeverIntermittentLate onsetRemissionPersistent
Recent wheeze60.4%13.1%12.4%5.6%8.4%
AHR78.7%7.8%1.8%7.2%4.4%
Atopy43.4%11.2%13.7%3.2%28.5%